Logo image of ALEUP.PA

EUROPLASMA (ALEUP.PA) Stock Fundamental Analysis

Europe - EPA:ALEUP - FR0014011QJ8 - Common Stock

1.06 EUR
-0.19 (-15.2%)
Last: 10/16/2025, 7:00:00 PM
Fundamental Rating

2

Overall ALEUP gets a fundamental rating of 2 out of 10. We evaluated ALEUP against 44 industry peers in the Commercial Services & Supplies industry. ALEUP may be in some trouble as it scores bad on both profitability and health. ALEUP is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALEUP has reported negative net income.
ALEUP had a negative operating cash flow in the past year.
In the past 5 years ALEUP always reported negative net income.
In the past 5 years ALEUP always reported negative operating cash flow.
ALEUP.PA Yearly Net Income VS EBIT VS OCF VS FCFALEUP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

Looking at the Return On Assets, with a value of -24.31%, ALEUP is doing worse than 90.91% of the companies in the same industry.
Industry RankSector Rank
ROA -24.31%
ROE N/A
ROIC N/A
ROA(3y)-28.67%
ROA(5y)-30.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALEUP.PA Yearly ROA, ROE, ROICALEUP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K 2K

1.3 Margins

With a Gross Margin value of 29.16%, ALEUP is not doing good in the industry: 68.18% of the companies in the same industry are doing better.
ALEUP's Gross Margin has improved in the last couple of years.
ALEUP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.42%
GM growth 5YN/A
ALEUP.PA Yearly Profit, Operating, Gross MarginsALEUP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

2

2. Health

2.1 Basic Checks

ALEUP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALEUP has been increased compared to 1 year ago.
ALEUP has more shares outstanding than it did 5 years ago.
ALEUP has a better debt/assets ratio than last year.
ALEUP.PA Yearly Shares OutstandingALEUP.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ALEUP.PA Yearly Total Debt VS Total AssetsALEUP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 28.62 indicates that ALEUP is not in any danger for bankruptcy at the moment.
ALEUP's Altman-Z score of 28.62 is amongst the best of the industry. ALEUP outperforms 97.73% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 28.62
ROIC/WACCN/A
WACC8.05%
ALEUP.PA Yearly LT Debt VS Equity VS FCFALEUP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M -30M

2.3 Liquidity

ALEUP has a Current Ratio of 0.77. This is a bad value and indicates that ALEUP is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ALEUP (0.77) is worse than 81.82% of its industry peers.
A Quick Ratio of 0.41 indicates that ALEUP may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.41, ALEUP is doing worse than 90.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.41
ALEUP.PA Yearly Current Assets VS Current LiabilitesALEUP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

4

3. Growth

3.1 Past

ALEUP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.00%, which is quite impressive.
Looking at the last year, ALEUP shows a very strong growth in Revenue. The Revenue has grown by 175.55%.
ALEUP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 68.20% yearly.
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)175.55%
Revenue growth 3Y62.99%
Revenue growth 5Y68.2%
Sales Q2Q%226.41%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALEUP.PA Yearly Revenue VS EstimatesALEUP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ALEUP.PA Yearly EPS VS EstimatesALEUP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2017 -5B -10B -15B -20B

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALEUP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALEUP.PA Price Earnings VS Forward Price EarningsALEUP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALEUP.PA Per share dataALEUP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALEUP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EUROPLASMA

EPA:ALEUP (10/16/2025, 7:00:00 PM)

1.06

-0.19 (-15.2%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)05-19 2025-05-19
Earnings (Next)10-29 2025-10-29
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.98B
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 93.75
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.01
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.31%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.16%
FCFM N/A
ROA(3y)-28.67%
ROA(5y)-30.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.42%
GM growth 5YN/A
F-Score6
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 11.65%
Cap/Sales 3.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.41
Altman-Z 28.62
F-Score6
WACC8.05%
ROIC/WACCN/A
Cap/Depr(3y)27.29%
Cap/Depr(5y)107.12%
Cap/Sales(3y)11.61%
Cap/Sales(5y)43.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)175.55%
Revenue growth 3Y62.99%
Revenue growth 5Y68.2%
Sales Q2Q%226.41%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-33.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.2%
OCF growth 3YN/A
OCF growth 5YN/A